You can buy or sell ALGS and other stocks, options, and ETFs commission-free!
Aligos Therapeutics, Inc. develops targeted, curative therapies for hepatologic diseases and viral infections. It engages in building a pipeline of drug candidates which targets multiple clinically validated mechanisms of action and are designed to achieve functional cure for CHB and become transformative treatment options for COVID-19 and NASH. The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA. The listed name for ALGS is Aligos Therapeutics, Inc. Common Stock.
Lawrence M. Blatt
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Mar 19, Pre-Market